Skip to main content

Advertisement

Springer Nature Link
Log in

Targeted fluconazole prophylaxis for high-risk very low birth weight infants

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Antifungal prophylaxis is increasingly used in very low birth weight (VLBW) infants who are at risk for severe fungal infections. Our objective was to assess the effectiveness of targeted fluconazole prophylaxis for high-risk VLBW infants. A retrospective cohort study with historical controls was performed. During the period 2007–2008, all high-risk VLBW infants (birth weight, ≤1,000 g; gestational age, ≤28 weeks; seven antimicrobial therapy or additional risk factors present) received fluconazole prophylaxis until risk factors were not present. Treated infants were compared to a gestational age- and birth weight-matched untreated cohort. Statistical analyses used univariate and multivariate analyses. The main outcome variable was a breakthrough fungal bloodstream infection (BSI). The prophylaxis cohort of 130 VLBW infants was compared to 319 control infants. The rate of fungal infections was significantly lower in the fluconazole prophylaxis group (1 of 130 vs. 19 of 319, p = 0.016); however, they did not differ in mortality (16.2 vs. 15 %, p = 0.77) or complications of prematurity. Fluconazole prophylaxis was associated with a significant decrease in candidal BSI (odds ratio, 0.05; 95 % confidence interval, 0.005–0.523). Selective vs. nonselective prophylaxis reduced the number of infants treated from 247 to 130. Conclusion Targeted fluconazole prophylaxis in VLBW infants is effective in preventing fungal infections without increasing the risk of BSI among low-risk infants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

Abbreviations

VLBW:

Very low birth weight

NICU:

Neonatal intensive care unit

BSI:

Bloodstream infection

OR:

Odds ratio

CI:

Confidence interval

References

  1. Adkins B, Leclerc C, Marshall-Clarke S (2004) Neonatal adaptive immunity comes of age. Nat Rev Immunol 4:553–564

    Article  PubMed  CAS  Google Scholar 

  2. Anonymous (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Opthalmol 123:991–999

    Article  Google Scholar 

  3. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al (1978) Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 187:1–7

    Article  PubMed  CAS  Google Scholar 

  4. Bendel CM (2003) Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis. Semin Perinatol 27:357–364

    Article  PubMed  Google Scholar 

  5. Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, National Institute of Child Health and Human Development Neonatal Research Network et al (2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117(1):84–92

    Article  PubMed  Google Scholar 

  6. Burwell LA, Kaufman D, Blakely J, Stoll BJ, Fridkin SK (2006) Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices. Pediatrics 118(4):e1019–e1026

    Article  PubMed  Google Scholar 

  7. Clerihew L, Austin N, McGuire W (2007) Cochrane Database Syst Rev. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. CD003850

  8. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al (2005) Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116:1353–1360

    Article  PubMed  Google Scholar 

  9. Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T (2006) Changing incidence of candida bloodstream infections among NICU patients in the United States: 1995–2004. Pediatrics 117:1680–1687

    Article  PubMed  Google Scholar 

  10. Friedman S, Richardson SE, Jacobs SE, O’Brien K (2000) Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 19:499–505

    Article  PubMed  CAS  Google Scholar 

  11. Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371(9606):75–84

    Article  PubMed  Google Scholar 

  12. Healy CM, Campbell JR, Zaccaria E, Baker CJ (2008) Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 121(4):703–710

    Article  PubMed  Google Scholar 

  13. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345(23):1660–1666

    Article  PubMed  CAS  Google Scholar 

  14. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossman LB (2005) Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1,000 grams birth weight. J Pediatr 147(2):172–179

    Article  PubMed  CAS  Google Scholar 

  15. Kaufman DA, Cuff AL, Wamstad JB, Boyle R, Gurka MJ, Grossman LB et al (2011) Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. J Pediatr 158(5):759–765.e1

    Article  PubMed  CAS  Google Scholar 

  16. Kaufman D, Fairchild KD (2004) Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 17:638–680

    Article  PubMed  Google Scholar 

  17. Makhoul IR, Bental Y, Weisbrod M, Sujov P, Lusky A, Reichman B, Network IN (2007) Candidal versus bacterial late-onset sepsis in very low birthweight infants in Israel—a national survey. J Hosp Infect 65(3):237–243

    Article  PubMed  Google Scholar 

  18. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B (2002) Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics 109:34–39

    Article  PubMed  Google Scholar 

  19. Manzoni P, Arisio R, Mostert M, Leonessa M, Farina D, Latino MA et al (2006) Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 117(1):e22–e32

    Article  PubMed  Google Scholar 

  20. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology et al (2007) A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356(24):2483–2495

    Article  PubMed  CAS  Google Scholar 

  21. Martin JA, Kung HC, Mathews TJ, Hoyert DL, Strobino DM, Guyer B et al (2008) Annual summary of vital statistics: 2006. Pediatrics 121(4):788–801

    Article  PubMed  Google Scholar 

  22. McCrossan BA, McHenry E, O’Neil F, Sweet DG (2007) Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed 92:F454–F458

    Article  PubMed  Google Scholar 

  23. Papile LA, Burstein J, Burstein AR, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92:529–534

    Article  PubMed  CAS  Google Scholar 

  24. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover BH, Pediatric Prevention Network et al (2001) Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the First National Point-Prevalence Survey. J Pediatr 139:821–827

    Article  PubMed  CAS  Google Scholar 

  25. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP, National Nosocomial Infections Surveillance System Hospitals (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 35(5):627–630

    Article  PubMed  CAS  Google Scholar 

  26. Uko S, Soghier LM, Vega M, Marsh J, Reinersman GT, Herring L et al (2006) Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 117(4):1243–1252

    Article  PubMed  Google Scholar 

  27. Vermont-Oxford trials network database project. Manual of operations (1993) Burlington, VT. Release 2.0

  28. Weitkamp JH, Ozdas A, LaFleur B, Potts AL (2008) Fluconazole prophylaxis for prevention of invasive fungal infection in targeted highest risk preterm infants limits drug exposure. J Perinatol 28:405–411

    Article  PubMed  CAS  Google Scholar 

  29. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S et al (1995) Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol 173:269–274

    Article  PubMed  CAS  Google Scholar 

  30. Zaghouani H, Hoeman CM, Adkins B (2009) Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 30(12):585–591

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors state that they have no conflicts of interest and that no funding was obtained for this study.

Author information

Authors and Affiliations

  1. Neonatal Intensive Care Unit, Schneider Children’s Medical Center of Israel, 14 Kaplan Street, Petah Tikva, Israel, 49202

    Asaph Rolnitsky, Lea Sirota & Gil Klinger

  2. Infectious Disease Unit, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel

    Itzhak Levy & Itamar Shalit

  3. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    Asaph Rolnitsky, Itzhak Levy, Lea Sirota, Itamar Shalit & Gil Klinger

Authors
  1. Asaph Rolnitsky
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Itzhak Levy
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Lea Sirota
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Itamar Shalit
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Gil Klinger
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Gil Klinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rolnitsky, A., Levy, I., Sirota, L. et al. Targeted fluconazole prophylaxis for high-risk very low birth weight infants. Eur J Pediatr 171, 1481–1487 (2012). https://doi.org/10.1007/s00431-012-1760-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-012-1760-2

Keywords